BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Harvard T.H. Chan School of Public Health - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Harvard T.H. Chan School of Public Health
X-ORIGINAL-URL:https://hsph.harvard.edu
X-WR-CALDESC:Events for Harvard T.H. Chan School of Public Health
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260515T130000
DTEND;TZID=America/New_York:20260515T150000
DTSTAMP:20260531T092512
CREATED:20260330T205708Z
LAST-MODIFIED:20260401T231458Z
UID:111360005918-1778850000-1778857200@hsph.harvard.edu
SUMMARY:Screening for Major Diseases — Does it help?
DESCRIPTION:Home / 404\n\n\n\n\n\n\n40 Years of the Health Professionals Follow-Up Study\n\n\n\n\n\n\n\n	\n		\n		\n			Hide caption\n		\n	\n	\n		\n		\n			Show caption\n		\n	\n\n\n	HPFS researchers gather outside of Harvard School of Public Health.\n\n\n\n\n\n\n\n\n\nTime \n\n\n\n\n\n\n\nEvent Type \n\n\n\n	Lectures/Seminars/Forums\n\n\n\n\n\n	\n		Register Today	\n\n\n\n\n\n\n\n\n\n\n\n\nThe Cutter Lectures on Preventive Medicine – 10th Symposium\n\n\n\nPart of the Cutter Lectures on Preventive Medicine series\, The 10th Cutter Symposium “Screening for Major Diseases—Does It Help?” will feature three separate lectures from expert speakers on the topic of screening for colorectal cancer\, prostate cancer\, and infectious diseases followed by a moderated Q&A segment with all the speakers. This symposium is open to the public & is virtual only. \n\n\n\nSchedule of talks: \n\n\n\n1:00PM  Introducing the Cutter SymposiumAlbert Hofman\, MD\, PhD1:05PMThe Power of Colorectal Cancer ScreeningHermann Brenner\, MD. MPHAbstract: Over 30 years ago\, in 1993\, a groundbreaking analysis of the US National Polyp Study was published\, which suggested that colonoscopic removal of colorectal polyps was associated with an 88% reduction of colorectal cancer incidence. Since then\, numerous observational studies and randomized trials have confirmed effectiveness of colorectal cancer screening\, even though most of them substantially underestimated screening effects for various reasons. Large heterogeneity in introduction of and adherence to screening programs across countries in the last three decades is mirrored in large heterogeneity of trends in colorectal cancer incidence and mortality. Modelling studies based on the accumulated evidence confirm that the vast majority of the approximately one million colorectal cancer deaths per year globally could be prevented by screening. 1:35PMControversies and Innovations in Screening for Prostate Cancer Lorelei Mucci\, ScD    Abstract: More than 1.6 million men across the globe are diagnosed with prostate cancer annually\, and it is the leading cause of cancer death in more than 50 countries. In randomized controlled trials\, screening with prostate specific antigen (PSA) has been shown to reduce cancer mortality over two decades. However\, PSA screening also has led to overdiagnosis of prostate cancers that have a low potential for metastasis and concomitant overtreatment of patients. What has ensued over the past two decades has been an active debate about the harms and benefits of screening\, guidelines that are often in conflict with one another\, and in the United States\, a substantial reduction in prostate cancer screening that is now tied to an uptake in incidence of metastatic prostate cancer. This talk will provide an overview of the history of PSA screening\, the evidence around risks and harms\, the controversies\, and recent innovations in approaches to accelerate a risk stratified approach to screening. 2:05PM       Diagnostics\, Screening\, and Surveillance in Pandemics Marc Lipsitch\, DPhilAbstract: This talk will describe challenges and opportunities for surveillance during large infectious disease events\, with lessons from COVID-19 and earlier pandemics. Active testing of population-based random samples provide numerous advantages over passive case detection in many situations\, while linked data on demographics\, severity\, and pathogen variant among other characteristics are far more valuable for decision making than the same data if unlinked. Better data can inform more efficient decisions about control measures that improve the ratio of disease control effectiveness to cost and disruption.2:35PMGeneral Discussion3:00PMClosing by Albert Hofman\n\n\n\nSpeakers will share their own perspectives; they do not speak for Harvard. \n\n\n\n\n\nSpeaker Information\n\n\n\n\n\n\n	\n		\n\n	\n		\n							Hermann Brenner\, MD\, MPH					\n				Professor of Epidemiology\, Heidelberg University\, Scientific Coordinator\, National Cancer Prevention Graduate School\, German Cancer Research Center (DKFZ)\, Heidelberg\, Germany\n			\n			\n												\n	\n\n\n\n	\n		\n						\n							Lorelei Mucci\, ScD						\n					\n				Professor of Epidemiology\, Head of the Cancer Epidemiology and Prevention Track\, Department of Epidemiology\, Harvard T.H. Chan School of Public Health\n			\n			\n							\n					\n	\n\n\n\n	\n		\n						\n							Marc Lipsitch\, DPhil 						\n					\n				Berberian Professor and Senior Fellow\, Center for International Security and Cooperation Professor of Medicine\, and Professor of Biology\, Stanford University\, Adjunct Professor of Epidemiology\, Harvard T.H. Chan School of Public Health\n			\n			\n												\n	\n\n\n\n	\n		\n						\n							Albert Hofman\, MD\, PhD						\n					\n				Stephen B. Kay Family Professor of Public Health and Clinical Epidemiology\, Chair\, Department of Epidemiology\, Harvard T.H. Chan School of Public Health\n			\n			\n												\n	\n\n	\n\n\n\n\n\n\n\n\nOrganizers\n\n\n\n\n\n\nDepartment of Epidemiology\n\n\n\n\n\n\n\n\n\n	\n		\n		\n			\n				\n					\n						Unleash your potential at Harvard Chan School.					\n					In addition to our degree programs\, we offer highly targeted programs through our Advanced Learning Academy\, directed and taught by Harvard faculty. \n											\n																															\n									\n										Degree Programs									\n								\n																															\n									\n										How to Apply									\n								\n																															\n									\n										Advanced Learning Academy
URL:https://hsph.harvard.edu/epidemiology/events/screening-for-major-diseases-does-it-help/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hsph.harvard.edu/wp-content/uploads/2026/03/Event-page_Cutter-Symposium-May-15-2026.jpg
END:VEVENT
END:VCALENDAR